Tumor Growth Parameters Estimation and Source Localization From a Unique Time Point: Application to Low-grade Gliomas by Rekik, Islem et al.
Tumor Growth Parameters Estimation and Source
Localization From a Unique Time Point: Application to
Low-grade Gliomas
Islem Rekik, Ste´phanie Allassonnie`re, Olivier Clatz, Ezequiel Geremia, Erin
Stretton, Herve´ Delingette, Nicholas Ayache
To cite this version:
Islem Rekik, Ste´phanie Allassonnie`re, Olivier Clatz, Ezequiel Geremia, Erin Stretton, et al..
Tumor Growth Parameters Estimation and Source Localization From a Unique Time Point:
Application to Low-grade Gliomas. Computer Vision and Image Understanding, Elsevier, 2013,
117 (3), pp.238–249. <10.1016/j.cviu.2012.11.001>. <hal-00813881>
HAL Id: hal-00813881
https://hal.inria.fr/hal-00813881
Submitted on 1 Jul 2013
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

Tumor Growth Parameters Estimation and Source
Localization From a Unique Time Point: Application to
Low-grade Gliomas
Islem Rekika, Ste´phanie Allassonnie`reb, Olivier Clatza, Ezequiel Geremiaa,
Erin Strettona, Herve´ Delingettea, Nicholas Ayachea
aINRIA, Asclepios Project, 2004 Route des Lucioles, BP 93, F-06902 Sophia Antipolis
Cedex, France
bCMAP Ecole Polytechnique, Route de Saclay, 91128 Palaiseau France
Abstract
Coupling time series of MR Images with reaction-diﬀusion-based models
has provided interesting ways to better understand the proliferative-invasive
aspect of glial cells in tumors. In this paper, we address a diﬀerent formula-
tion of the inverse problem: from a single time point image of a non-swollen
brain tumor, estimate the tumor source location and the diﬀusivity ratio
between white and grey matter, while exploring the possibility to predict
the further extent of the observed tumor at later time points in low-grade
gliomas. The synthetic and clinical results show the stability of the located
source and its varying distance from the tumor barycenter and how the esti-
mated ratio controls the spikiness of the tumor.
Keywords: diﬀusivity ratio, source estimation, Eikonal Equation,
reaction-diﬀusion glioma growth modeling
1. Introduction
Brain gliomas represent about 50% of all primary brain tumors [1] and
can be classiﬁed according to their grade of malignancy. Low grade gliomas
Email addresses: islem.rekik@gmail.com (Islem Rekik),
stephanie.allassonniere@polytechnique.edu (Ste´phanie Allassonnie`re),
olivier.Clatz@inria.fr (Olivier Clatz), ezequiel.Geremia@inria.fr (Ezequiel
Geremia), erin.stretton@gmail.com (Erin Stretton), herve.Delingette@inria.fr
(Herve´ Delingette), Nicholas.Ayache@inria.fr (Nicholas Ayache)
Preprint submitted to ComputerVisionAndImageUnderstanding February 5, 2013
(LGG) are slow invaders of brain tissue as they keep growing for many years,
presenting one of the most controversial decision treatment areas. High
grade gliomas (HGG) remain unfortunately incurable with an average life
expectancy of one year after its discovery, eventually creating symptoms due
to an increase of the intracranial pressure or swelling around the tumor. The
diagnosis of brain gliomas includes the analysis of various MRI sequences of
the brain which partially reveal the tumor invasion. Based on those images
and other clinical information, neurologists try to determine the grade of
the gliomas and to estimate their current and further spatial extent and if
possible their source location.
For more than a decade, mathematical models of brain tumors have been
devised to help clinicians answer these questions. Microscopic models study
the cellular mechanisms [2, 3, 4, 5] that explain the growth dynamics of
gliomas at a microscopic scale. On the other hand, macroscopic models
pioneered by Murray [6] describe the evolution of tumor cell density. How-
ever, those quantities cannot be directly observed in clinical medical images,
but it is commonly assumed that visible tumor boundaries correspond to an
isovalue of this density. More realistic reaction-diﬀusion models have been
proposed by Swanson et al. [7] based on the fact that tumor cells migrate
faster on white matter ﬁbre tracts myelin sheaths [8]. They have been fur-
ther reﬁned by Jbabdi et al. [9] and Clatz et al. [10] by considering an
anisotropic diﬀusion in the white matter whose diﬀusion tensor is estimated
from those acquired in DT-MRI.
A key issue for those models to answer clinical questions is their personal-
ization, i.e. the estimation of some patient-speciﬁc parameters from medical
images. The main parameters to be identiﬁed based on reaction-diﬀusion
models were pointed out in [11] as a combination of tumor diﬀusion tensors
in white and grey matter, its proliferation rate, its initial point and its initial
time. Several authors have estimated patient-speciﬁc parameters manually
[10] or through major model simpliﬁcations [12]. Colin et al. in [13] used a
reduced model based on Proper Orthogonal Decomposition (POD) in order to
identify growth parameters of pulmonary nodules in CT images. Konukoglu
et al. [14, 15, 16] have proposed an approach to automatically and accurately
personalize brain tumor models. They ﬁrst remarked that given time series
of brain MR images, only the motion of a tumor front can be observed and
therefore only the three following parameters can be recovered : diﬀusivity in
the white dw and grey matter dg as well as the initial time T0. Furthermore,
since the tumor cell density are only observed in MR images through visible
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tumor boundaries corresponding to an isovalue, the reaction-diﬀusion equa-
tions can be advantageously replaced by an Anisotropic Eikonal Equation
(AEE) [16] which models the time at which a tumor front reaches a given
point. By minimizing the distance between the segmented tumor and the
simulated one, they were able to estimate uniquely those three parameters
and test the prediction of future tumor evolution from at least a pair of
images.
In this paper, we tackle a slightly diﬀerent problem than the one ap-
proached by previous authors. Instead of estimating the speed of tumor
growth from a time series of images, we aim at characterizing the nature of
the glioma, more precisely LGG, from a single MR image. Indeed, we hypoth-
esized that the tumor shape is dependent on the proliferating or inﬁltrating
nature of the tumor. Contrary to HGG where the presence of brain edema
is common and usually associated with tumor malignancy, LGG are slowly
growing tumors with a minimal surrounding edema [17, 18, 19]. Since our
methodology main focus is on LGG, we will not consider the edema-induced
mass eﬀect in our further formulation of the tumor growth model. Therefore,
the anatomical boundaries such as the ventricles’ will remain static as the
tumor grows.
Given a segmented brain glioma from an MR image, we solve an inverse
problem in order to estimate the diﬀusivity ratio dw/dg and the tumor source
position. By localizing the tumor source and estimating the invaded tissue
characteristic using this ratio dw/dg our objective is to provide clinicians with
new indices that can be used for diagnosis from the ﬁrst acquired MR images,
combined with a subsequent prediction of tumor invasive margins as it grows
from the initially observed boundary. This additional information may help
in surgical and/or radio-therapeutic treatment planning especially when it
comes to determining the margins for applying the therapy. The problem of
tumor seed localization was recently raised in [20], where a reaction-diﬀusion
based joint estimation of tumor evolution parameters was combined with a
multimodal deformable registration framework. This approach focuses on
the MR image registration with an atlas providing the estimation of the
initial seed location as a by-product. Later on, it was extended to a joint
segmentation and deformable registration between multi-sequence brain MR
image with gliomas and a probabilistic brain atlas of a healthy population [21,
22]. These recent publications targeting the localization of tumor seeds, the
quantiﬁcation of the mass eﬀect and its white matter diﬀusion coeﬃcient was
based on a normal atlas.
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In this paper, we investigate a diﬀerent problem from registration or seg-
mentation in low-grade gliomas. Our approach addresses a spatio-temporal
tumor evolution with the estimation of the diﬀusivity ratio and the position
of its source. Additionally, after solving the inverse problem, we evaluate the
stability of the location of tumor sources over time and analyze the relation-
ship between the tumor source and tumor barycenter as both locations have
been assumed to match in past studies [23, 24, 25, 26, 27]. Finally, know-
ing the diﬀusivity ratio dw/dg and the tumor source from a single image,
we evaluate whether this information gives insights into predicting further
tumor shape evolution in two distinct cases of low-grade gliomas.
2. Material and Method
2.1. MR Glioma images
In this work, we assume that for a given patient, one MR FLAIR image of
the brain has been acquired, showing visible boundaries of glioma cells. We
also assume that a Diﬀusion Tensor MR Image (DT-MRI) is also available
and acquired at the same time as the FLAIR image. While FLAIR images are
acquired in routine on patients with brain tumors, this is unfortunately not
the case for DT-MRI. The extent of the tumor has been manually segmented
in FLAIR images. Similarly, brain masks have been manually delineated
on those images from which brain ventricles have been removed by a simple
thresholding of the signal. Also white matter regions have been isolated by
thresholding the voxels with the largest eigenvalue in the DT-MRI.
Objective: From the segmented tumor in the FLAIR image, our objective
is to provide a quantitative analysis of the tumor shape which is not simply
based on geometry (spheroid vs star-shaped) but based on simple biophysics
growth principles. Indeed, two quantities are estimated in this analysis: the
tumor source position and the diﬀusivity ratio between white matter and grey
matter. This information may provide additional hints about the nature and
the future progression of the tumor.
Data issues: Collecting LGG data with DT-MRIs is not a very straight-
forward task since diﬀusion MR is a quite recent technology [28], rarely used
in the common clinical practice and furthermore acquired DT-MRI may have
various anomalies like holes, low resolution and signal distortion. This is
particularly true around any tumor lesion. This lack of information may be
compensated by assuming the symmetry of the brain. For this, we perform
a symmetrization process to “reinitialize” the region where the tumor grew
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and induced a diﬀusion signal distortion. Hence, for a proper simulation of
tumor growth, we have corrected the tensor ﬁeld by making the hypothesis
that the DT MRI was originally symmetric with respect to the mid-sagittal
plane. Thus the DT-MRI voxels corresponding to the largest extent of the
tumor have been modiﬁed by symmetrizing and copying the voxels from the
healthy brain hemisphere. However, this symmetrization process is prone to
the following diﬃculties:
a- the DT MRI is asymmetric especially in white matter where about
50% of the contralateral tumor volume has zero Fractional Anisotropy (FA)
values, while in the corresponding aﬀected region where the tumor grew, the
diﬀusion signal exists with a remarkable distortion (see Fig 1-a where the FA
tumor map is darker than the contralateral part with a signiﬁcant absence
of symmetry).
b- even with a reliable DT-MRI symmetry, about 50% of the contralat-
eral non-pathological symmetric volume to the tumor volume has no DT (i.e
FA) signal. In Fig 2-a, the presence of large black hole in the FA signal in
the contralateral part to the tumor invasion area presents a major barrier to
diﬀusion tensor-guided glioma evolution simulation. To cope with this DT
signal-missing problem, an interpolation algorithm based on isotropic diﬀu-
sion (solving the heat equation) was applied to estimate the missing tensors
from neighboring regions. This is done by applying a Gaussian convolution
separately on the six components of the diﬀusion tensors.
Dataset: By excluding LGG cases with completely distorted or missing
DTI, we succeeded to include four LGG patients. The ﬁrst case, a.k.a pa-
tient A, has developed a second grade astrocytoma classiﬁed as a low-grade
glioma. Four successive time points of T2 ﬂair MR images with a resolution
of 0.99 × 1 × 2.16 mm3 were acquired and visible tumor boundaries were
manually delineated by an expert. A DT-MRI image was also acquired at
the ﬁrst acquisition time point. As expected, the white matter ﬁber tracts
are perturbed by the tumor growth and the DT-MRI signal near the tumor
does not capture the original diﬀusion tensors of the brain at the onset of the
disease. Therefore, we used the symmetrization process to reset the aﬀected
area to non-pathologically spatially deviated tensors (see Fig 3 where the
white matter diﬀusion tracts were beautifully recovered).
The second case, a.k.a patient B, suﬀers from a low-grade glioma and
four MR images were acquired at distinct time points with a resolution of
0.89 × 0.97 × 0.97 mm3. Only one DT-MRI was acquired during the initial
scanning process and the tumor region of the DT-MRI has been symmetrized
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similarly to patient A. In addition, the DT-MRI includes small holes in the
opposite region to the tumor that were successfully interpolated.
The third case, a.k.a patient C, with LGG has three acquisition time
points with a resolution of 2× 2× 2 mm3. In this particular case, displayed
in Fig 1, we encountered diﬃculty (-a-) where the DT-MRI is not fully sym-
metric.
The fourth case, a.k.a patient D, with a resolution of 2× 2× 2 mm3 was
not symmetrized due to the large holes in the symmetric region to the tumor
as show in Fig 2-a. Therefore, we interpolated the holes in the aﬀected tissue
without the symmetrization process.
2.2. Tumor Growth Modeling : from reaction-diﬀusion to Eikonal equations
Glial cells dynamics are essentially governed by two biological phenom-
ena : proliferation and invasion. They can be jointly modeled by a reaction-
diﬀusion equation which describes the change over time of the normalized




= ∇. (D(x)∇u) + ρu(1− u)
D ∇u. n∂Ω = 0 (1)
where ρ is the proliferation rate, D the local diﬀusion tensor, and n∂Ω is
the normal vector at the domain boundary surface ∂Ω. In the ﬁrst equation,
the proliferation of tumor cells follows a logistic growth parameterized by ρ
whereas the tumor inﬁltration into neighboring neural ﬁbers is captured by
an anisotropic diﬀusion parameterized by D. The second equation indicates
that there is no ﬂux of tumor cells outside the domain Ω.
The diﬀusion tensor is a deﬁnite positive and symmetric 3 × 3 matrix
whose value may be linked to Diﬀusion Tensor MRI (DT-MRI) [9]. Indeed,
it characterizes the motility of tumor cells that is considered to be isotropic
in grey matter but anisotropic in white matter. More precisely, the tumor
diﬀusion tensor (TDT) may be written as D(x) = dgI3 in grey matter, where
dg is the diﬀusivity coeﬃcient.
In white matter, there are several approaches to link the TDT D(x)
with the DT-MRI signal Dwater(x). Clatz et al. [10] proposed to have D(x)
proportional to Dwater(x) whereas Jbabdi et al. [9] have introduced a formu-
lation which takes into account the possible equality of the two largest eigen-
values corresponding to a possible ﬁber crossing. Due to high anisotropies
of Dwater(x) in most parts of the white matter, these two approaches lead
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however to diﬀusivities that are much lower than dg in the directions orthog-
onal to the ﬁbers, which is questionable. Furthermore, the high ratios of
anisotropy encountered in those two expressions also lead to large computa-
tional times.
In this paper, we propose to use the following white matter tumor diﬀu-
sion tensor:
D(x) = V(x)[diag(e1(x)dw, dg, dg)]V(x)
T (2)
where dw is the white matter diﬀusivity coeﬃcient, V(x) represents the ma-
trix of sorted eigenvectors of Dwater(x) and e1(x), is the normalized largest
eigenvalue (between 0 and 1) of Dwater(x). With this choice, tensors have
a non-homogeneous anisotropy ratio which is always less than dw/dg but is
maximized at the center of the white matter ﬁbers and continuously decreases
towards their boundaries. By simply dividing the duration of tumor evolution
simulation of its propagating front using our adopted diﬀusion tensor 2 by
the simulation duration as we used the diﬀusion tensor formulas presented in
[9] (we precisely refer the reader to formulas A11 and A12), we have noticed
that our choice speeds-up the computational time by a factor of 200 without
any signiﬁcant diﬀerences in performance. In fact, the use of a more nonlin-
ear (more anisotropic) diﬀusion tensor ﬁeld increases the computational time
of the solution as the characteristic direction of the recursive anisotropic fast
marching algorithm used to solve the AEE 5 becomes harder to ﬁnd. This
also may be explained by the fact that below a certain anisotropy ratio, the
diﬀerence in tumor growth simulation is hardly noticeable.
The reaction-diﬀusion equation (1) is not practical when dealing with clin-
ical images. Indeed, in MR images tumor cell density u cannot be observed
but only the visible tumor boundary can. Hence, a front motion approxi-
mation for the reaction-diﬀusion equation was introduced by Konukoglu et
al. [16] assuming that the visible contour is associated with iso-density con-
tour u = 0.4 [29]. They introduced an Anisotropic Eikonal Equation (AEE)
describing the time T (x) at which the evolving tumor front passes through
the location x. In its simplest form, the AEE writes as:
F
√
∇T TD∇T = 1 with F = 2√ρ (3)
However, such approximation of equation 1 is too simple and Konukoglu
et al. then proposed to account for the fact that the tumor front speed
increases over time to reach an asymptotic value equal to 2
√
ρ nTDn where
n is the normal direction of the front. The time-dependent speed of the
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Furthermore, the front curvature κeff (x) also plays a role in the front speed
as the front slows at high curvature points. This is especially important at
the early stage of the tumor growth when the front is similar to a small






− 0.3√ρ (1− e−|κeff |/0.3√ρ) (5)
This last formulation is no longer a Hamilton-Jacobi equation due to the
second-order curvature term and therefore cannot be solved by fast sweeping
methods such as the Anisotropic Fast Marching (AFM) [14]. However, a
multi-pass approach was proposed [16] to solve eﬃciently this equation by
applying several times the AFM method while estimating the curvature front
from previous iterations. The AFM method is recursive and the larger the
tensor anisotropy the more iterations are needed to compute the character-
istic direction of equation (5). Our white matter TDT of equation (2) limits
the anisotropy ratio and therefore leads to reasonable computational times
(typically few minutes for a tumor growth from a seed point).
2.3. Parameter estimation problem from a unique MR image
Based on the previously exposed mathematical model, we can simulate
the growth of a glioma given its initial source S(x) for which we assume that
T (S(x)) = 0. From this boundary condition and the knowledge of diﬀusivity
dw, dg and proliferation rate ρ we can compute the time T (x) at which the
visible tumor front reaches a given point. The isocontours of the ﬁeld T (x)
correspond to the successive shapes of the visible tumor boundary over time
as shown in Fig 4. The speed on the front is not constant but its asymptotic
value is 2
√
ρdg in grey matter and 2
√
ρdw in white matter.
In this paper, we are interested in solving the following inverse problem:
given a visible tumor boundary SSeg in an MR image, can we extract the
growth parameters dw, dg, ρ, TObs and source location S(x) that best explain
the observed tumor boundary ? The duration TObs between the onset of the
tumor and the MR image acquisition is indeed also unknown.
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Based on [16], it has been already established that several combinations
of ρ, dw, dg lead to the same front speed and therefore the same tumor growth
simulations. Therefore, it is suﬃcient in this inverse problem to consider a
ﬁxed value of the proliferation rate ρ corresponding to the tumor grade and
to estimate the remaining parameters. However, unlike [15, 16] this problem
can be further simpliﬁed by realizing that the front speed cannot be estimated
since TObs is unknown. If one multiplies the diﬀusivities by a scale factor α
then one obtains the same isocontours for a propagation time divided by√
α1. This means that the simulated tumor isocontours do not depend on




In the remainder, we will show that this ratio is related to the spikiness of
the tumor.
A simple sensitivity analysis has led to conclusion that solving the in-
verse tumor growth problem only depends on the following 2 parameters:
the source location S(x) and the spikiness index r. Here, the “spikiness
index” represents a biology-driven estimated measure which quantiﬁes the
tortuousness of the boundary of the tumor as displayed on MR axial slices
(see Figure 4-A), an index related to the frequency at which the tumor shape
bends and twists. We consider that {S(x), r} appropriately characterize well
a tumor extent if its visible boundary in MRI, SSeg, is an isocontour of the
simulated tumor growth initiated at S(x) with diﬀusivity ratios equal to r.
Therefore, we propose to estimate the patient speciﬁc parameters by mini-
mizing the following criterion:













1This is not strictly true if one uses the speed term F taking into account the transient
speed as in Equation 4 or 5. However, the diﬀerence in simulations due to the absolute
value of the diﬀusivities was found to be negligeable.
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where N is the number of points belonging to the manually delineated tu-
mor boundary SSeg. In these equations, T and Cρ are respectively the mean
time value and time standard deviation computed over the tumor bound-
ary. Our motivation to use this criterion to get good estimates of our un-
knowns (S(x, y, z), r) derives from the fact that a tumor boundary (propa-
gating front) is simultaneously deﬁned as an isotime and an isosurface. Thus,
to quantify how good is the estimation of the parameters guiding the spatio-
temporal evolution of the tumor shape, we need to quantify how closely the
simulated isosurface matches the observed one (manually delineated bound-
ary). From a time perspective, this also implies that when measuring the
time T at every point x of the manually delineated tumor isotime boundary,
its value T (x) will be constant in the best case scenario where the simulated
tumor front exactly matches the observed tumor boundary. Therefore, min-
imizing the time standard variation criterion Cρ over the delineated tumor
boundary SSeg will guide the algorithm towards a better estimation of the
two key parameters driving the invasive tumor front into ﬁtting the succes-
sive MR observed boundaries. Note that Cρ is normalized by T because the
criterion should be made independent of the tumor front speed and therefore
the mean time T .
In order to eﬃciently minimize the previously outlined criterion, we use
the multidimensional unconstrained minimization algorithm without gradi-
ent introduced by Powell in [30]. This algorithm suits our case since our
parameters are bounded in both biological and geometrical spaces. More-
over, the derivative of minimization criterion Cρ is not easy to compute. To
better study the convergence of this algorithm and evaluate its outcome,
15 tests were performed using synthetic tumors. Further evaluation of this
method was then studied using real data: two patients with LGG.
2.4. Synthetic Data: synthetic tumor generation process
In order to validate our parameter estimation, we produce synthetic tu-
mor MR images, where the initial tumor location and diﬀusivity ratio are
known. The procedure of generating synthetic tumors relies on choosing a
seed point S0 in either white or grey matter and the proliferation rate ρ to one
of the following values 0.008, 0.012, 0.024/day. The tumor front propagation
is simulated with a white matter diﬀusion rate dw and grey matter diﬀusion
rate dg whose ratio varies between 1 and 100 (considered to be a biologically
valid range) using equation (5). The growth simulation is stopped at a speci-
ﬁed time TObs thus leading to a time distance map as seen in Fig 4. Diﬀerent
10
synthetic tumors were created at diﬀerent anatomical locations with diﬀerent
sizes and asymptotic speeds of growth in both white and grey matter.
3. Results
3.1. Convexity of the minimization function: a convergence study
To check the convergence of the Powell minimization algorithm to the
initially set parameters, we study the convexity of the minimization criterion
C (see Equation (6)) for the four scalar parameters [Sx, Sy, Sz, r], writing
separately the coordinates of the tumor source location. We proceed by
alternatively ﬁxing some parameters to their ground truth values and opti-
mizing the remaining ones with the proposed minimization process. In Fig 5,
we can clearly see the convexity of the minimization surface plotted after set-
ting the diﬀusivity ratio r and one of the source coordinates to their right
values.
The convexity of the minimization criterion Cρ was successfully checked
also when optimizing three parameters and setting the fourth one at its true
value. The fact that the minimization criterion appears to be convex at the
vicinity of the ground truth parameters is reassuring about the observability
of the four parameters. However, the functional may still have local minima
and practical optimization results will be discussed in the next sections.
3.2. Synthetic data
We evaluated our method on 15 synthetically generated tumors with a
diﬀusivity ratio ranging from 1 to 100. The algorithm succeeded to identify
the original tumor source with a mean error of 0.42mm and a standard devi-
ation of 0.36mm. Moreover, it always converges to the real diﬀusivity ratio
dw/dgwith a mean error equal to 0.18 and a standard deviation of 0.06.
Furthermore, we use this synthetic data to provide a better understanding
of the diﬀusivity ratio r. The ﬁrst row of Fig 6 shows how the shape of the
tumor boundary can switch from “sphere-like”to “star-like”as the diﬀusivity
ratio value jumps from 1 to 50. Although the displayed tumors in the third
row are of diﬀerent sizes, the correlation between tumors’ shape spikiness
and the value of the diﬀusivity ratio r ∈ [1− 100] is clear.
Besides, we also notice from the second row of Fig 6 similar tumor con-
tours in terms of spikiness and irregularity when ﬁxing the diﬀusivity ratio
at the same value and varying the location of the initial tumor seed. This
11




In clinical data, no ground truth values of the parameters are available
and therefore additional criteria must be introduced in order to assess the
quality of the parameter estimation.
After the optimization of criterion 6, we extract the simulated isocon-
tour which is closest from the visible tumor boundary in MRI. Computing
symmetric distances between the two surfaces provides a quantitative infor-
mation about how well the tumor shape can be explained by the proposed
tumor growth model. We detail below the proposed approach.
We extract the closest isocontour deﬁned by time ˆTObs by optimizing
CisoT ime(50%)(T ) :
ˆTObs = min
T
CisoT ime(50%)(T ) (8)
The criterion CisoT ime(50%)(T ) is deﬁned as the median symmetric distance
between the visible tumour boundary SSeg and the isosurface SˆisoT ime at time
T . More precisely, for each voxel of SˆisoT ime (resp. SSeg) its closest distance
from SSeg (resp. SˆisoT ime) is computed through a distance map and added to
a list. The median value of that list is then taken as CisoT ime(50%)(T ). The
optimization of the functional is done with the Powell algorithm [30] already
used for solving the general inverse problem and requiring few estimations of
the functional. The range of time value for the optimization is constrained





(T (x)− T )2
N
We also compute other robust distance criteria CisoT ime(y%)(T ) by taking
the y% quantile of the symmetric distances.
Once the closest isochrone surface SˆisoT ime is estimated, we deﬁne the
symmetric distance between (S, SˆisoT ime) as the ﬁrst evaluation criterion:
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CsymDist(SSeg, SˆisoT ime) =
∑
x∈SSeg






where d denotes the closest Euclidean distance between a point and a surface.
We can also measure the similarity between the visible tumor volume Vseg
and the simulated tumor volume VisoT ime:
Coverlap(Vseg, VisoT ime) =
Vseg ∩ VisoT ime
0.5 (Vseg + VisoT ime)
(10)
3.3.2. Study of Patient A
For patient studies, we take advantage of the fact that several FLAIR MR
images are available for diﬀerent time points. We ﬁrst check the stability of
source locations for the M time points per patient and correlate the spiki-
ness index with the observed tumor evolution. To estimate the two target
parameters [S(x), r], the proliferation rate was ﬁxed to 0.012/day. Table 1
represents the outcome of the estimation method for the four time points (t1,
t2, t3, t4) of Patient A.
t1 t2 t3 t4
S(x) (120, 111, 31) (120, 111, 31) (122, 115, 30) (121, 116, 30)
d(G, S) in mm 2.00 1.73 1.42 5.38
r 41.98 40.47 40.58 41.38
Table 1: Outcome of the minimization algorithm of Patient A which was separately com-
puted at four time points. The distance d denotes the Euclidean distance between the
tumor barycenter G and its estimated source S.
We can clearly observe in Table 1 the stability of the tumor source location
and the fact that for the ﬁrst 3 time points this location is very close to the
tumor barycenter since the Euclidean distance between them d(G, S) ranges
from 1.42mm to 2mm. Nonetheless, for the fourth time point, the estimated
tumor source distance from its barycenter is 5.38mm. Moreover, the diﬀusion
rate r is mainly constant. In fact, patient A showed a very slow and quasi-
static evolution of the tumor boundary between the second and the third
acquisition time points. Our simulation model depicts this static evolution
13
CsymDist in mm Coverlap in %
(PatientA, t2) 1.97 85.63
(PatientA, t3) 1.79 87.76
(PatientA, t4) 1.74 88.04
(PatientB, t2) 1.53 82.20
(PatientB, t3) 1.48 84.79
(PatientB, t4) 1.13 88.02
Table 2: Prediction evaluation based on the error measures CsymDist and Coverlap com-
puted for Patient A and B to predict the evolution of the tumor at speciﬁc time points ti
using the minimization outcome of the previous time ti−1.
behavior as the corresponding estimated spikiness index r shown in Table 1
remains quasi-static (r = 40.47 at t2 and 40.58 at t3), which is in line with
the identical appearance of the estimated tumor red boundaries shown in
the ﬁrst and second rows of Figure 7. However, it is worth noting that the
algorithm failed to catch the tiny bump that appeared in the tumor boundary
at t3 (see ﬁrst column, row 1 and 2 in Figure 7). This can be explained by
the fact that the algorithm is based on a mean error minimization process,
which therefore accounts for a mean morphological change in tumor shape
over all the axial slices included in the tumor volume.
Second, we study the possibility to predict further spatial tumor bound-
aries evolution based on parameter evaluation. More precisely, after estimat-
ing patient speciﬁc parameters at time ti, we run a forward simulation using
those estimated parameters trying to predict the tumor invasion process as
time evolves. We then proceed by estimating the closest predicted isocontour
from the observed tumor boundary at time ti+k as described in section3.3.1.
Fig 8 and Table 2 display the outcomes of the evaluation criteria for every
time point.
We notice a limited discrepancy between the observed contour at time
point ti and the predicted one at ti+1 since the symmetric distance between
these contours CsymDist ranges from 1.74 mm to 1.97 mm. Moreover the
median distance error CisoT ime(50%) ranges from 1.44 mm to 1.68 mm and
the volume overlap Coverlap between the real tumor volume and the extracted
one ranges from 85.63% to 88.04%. It is remarkable that the estimated
parameters at a speciﬁc time point ti captures the tumor spatial evolution
at the successive time point ti+1. As highlighted in Fig 8, the estimated-
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t1 t2 t3 t4
S(x) (34, 145, 117) (35, 141, 117) (34, 141, 118) (34, 140, 119)
d(G, S) in mm 5.09 5.47 5.09 4.24
r 6.45 37.15 30.12 47.70
Table 3: Outcome of the minimization algorithm of Patient B separately computed at four
time points.
parameters based prediction shows promising results.
3.3.3. Study of Patient B
The parameter estimation outcome for Patient B at its four time points
is summarized in Table 3. The obtained results conﬁrm the stability of the
tumor source location. At every time point, the distance between the tumor
barycenter and the located source exceeds 4 mm, meaning that the tumor
source may not be close to its barycenter. Unlike Patient A, the spikiness
index value r increases as time evolves as it can also assessed visually in
Fig 9.
Despite the poor signal quality of the DT-MRI, the evaluation criteria
conﬁrm that the estimated parameters were adequate to spatially predict
the tumor front propagation. In fact, the symmetric distance CsymDist be-
tween the real front observed at ti and the extracted one at ti+1 ranges from
1.13 mm to 1.53 mm. The volume overlap Coverlap ranges from 82.20% to
88.02% (Table 2). The median distance error CisoT ime(50%) ranges from 0.92
mm to 1.16 mm (Fig 8). Fig 10 shows that the algorithm succeeded to spa-
tially capture the geometric behavior of the evolving tumor. However, the
maximum distance error CisoT ime(100%) reaches high values ranging from
7.10 mm to 11.97 mm. These outliers are related to the interpolated holes in
the DT-MRI where the simulated propagating front fails to capture the real
tumor invasion process.
3.3.4. Study of Patients C and D
In both patient C and D, the estimated source remained stable from
the ﬁrst time point to the third one as the distance between the succes-
sively estimated sources d(St1 , St2) and d(St1 , St3) did not reach a value over
1.42mm. The estimated diﬀusivity ratio for Patient C remained constant
as time evolves (r = 7.92), a spikiness value in concordance with the round
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shape of the tumor boundary and its very slow evolution between t1 and t3
as shown in Fig 11. The spatial disparity between the estimated source and
the barycenter did not exceed 1.8mm. For Patient D, the estimated diﬀu-
sivity ratio varied from rt1 = 20 to rt2 = 16.2 then increased to rt3 = 23.8.
The successively estimated high diﬀusivity ratios are in line with the tumor
boundary spikiness shown in Fig 2-b. The computed distance between the
estimated source and the tumor barycenter varied from 1.42mm at t1 to 3mm
at both t2 and t3.
4. Discussion
The patient-speciﬁc parameter estimation method presented in this paper
uses two main ingredients: the traveling front approximation presented by
Konukoglu et al. [16] transformed into the AEE and the Powell minimiza-
tion algorithm. We have shown using a limited number of LGG cases that
our approach could provide clinicians with two fundamental tumor dynamics
characteristics: the spatial position of tumor seed point and its diﬀusivity ra-
tio. Our optimization approach has been successfully evaluated on synthetic
data where ground truth is available.
At this point, we have noticed the quasi-stability of the located source
in both clinical cases, which is reassuring. Another key ﬁnding is related to
the distance between the located source point and tumor barycenter. For
Patient B, this distance ranges from 4.24mm to 5.47mm and for the 15
synthetically generated tumors, computed distance ranges from 1.42mm to
over 13mm. The disparity between the computed source and its barycenter
maybe explained by the spikiness index. Indeed, it is intuitive that “sphere-
like” tumors have a source which might be very close to its barycenter but
“star-like” tumors or spiky tumors are prone to greater disparities. In the
latter case, the barycenter may even end-up outside the tumor shape. This
outcome contradicts the assumption that the tumor source is its barycen-
ter as assumed in some studies as in [23] (tumor classiﬁcation process based
on the correlation between its located barycenter and molecular proﬁle ),
in [24] (MGMT gene methylation status prediction study in glioblastomas)
and in [25, 26, 27] (tumor growth simulation using cancerous cell concentra-
tion gradient computed from the center of tumor mass). Therefore, tumor
barycenter-derived conclusions may not seem fully reliable and could cloud
the true biological phenomena inﬂuencing tumor growth patterns. Further-
more, as noticed in Table 1, the source-to-barycenter distance ranging from 1
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to 5mm in a tumor of 10mm-size demonstrates that choosing the barycenter
as a source estimator leads to a large bias.
In Patient A, there is a jump of the source-barycenter distance value from
1.42mm to 5.38mm. This may be explained by a recent study from Bohman
et al. [31] aiming at a better understanding of glioma ontogeny (development
from earlier stage) within the complexity of brain anatomy. In fact, Bohman
et al. concluded that as the tumor grows, its boundary approaches the ven-
tricles and the closer its “seed position ” is to the ventricles, the larger the
tumor would be. This conclusion agrees with our observation in Fig 7 where
the tumor boundary becomes more distorted as it seems to be more “pulled”
towards the left lateral ventricle. Note that while Bohman et al. use a basic
geometric method to estimate the tumor barycenter, it mentions a discrep-
ancy between barycenter and tumor source ranging between 1.25 mm and 15
mm. This is in agreement with our synthetic study and we hope that this
work could provide a better understanding of tumor ontogeny.
According to our study, the tumor shape irregularities seems to be well
correlated with the diﬀusivity ratio r. Setting the spikiness index leads to
similar irregular tumor contours up to the geometry of their neighboring
brain structures (presence of the ventricles for instance). As a matter of
fact, the quasi-stability of this ratio for Patient A is justiﬁed by the quasi-
stability of its shape over time. Its high values ranging from 40.5 to 42 agrees
with its “V-like” irregularity (Fig 7). On the other hand, for Patient B, this
ratio raises from 6.45 to 47.70 as its shape evolves from a “sphere-like” to
a “star-like” (Fig 9). Interestingly, in a recent paper [32], a diﬀerent ratio
(dw/ρ) was used to quantify the diﬀusivity of the tumor boundary where a
low white matter diﬀusivity rate over proliferation ratio indicates a not very
inﬁltrative glioma (bulky), whereas high ratio deﬁnes diﬀuse tumor. The
main objective was to determine whether the tumor recurrence is a bulky or
diﬀuse-type recurring tumor. We believe that a comparison between both
of these ratios (dw/dg and dw/ρ) in future research works will be a valuable
step in determining the patient-speciﬁc factors guiding tumor growth.
For patients C and D, which had DT-MRI anomalies as shown in (Fig 1
and 2), our method proved its robustness as the estimated tumor source
remained stable as time evolved. The symmetrization process induced a
tremendous loss in white matter anisotropy as most of the ﬁbers along which
the tumor originally grew disappeared as demonstrated in (Fig 1) through
FA histograms comparison. Nevertheless, the algorithm converged to a low
diﬀusivity ratio value (r = 7.92). That was visually proven to be in con-
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cordance with the tumor “roundness” (Fig 11) and also remained constant
throughout time, a fact in correlation with the very slow and slightly un-
changed tumor boundary from t1 to t3. The Euclidean distance between the
estimated tumor source and its barycenter did not go over 2mm, which was
quite expected when noticing the roundness of the tumor shape.
Patient D did not undergo the symmetrization process because of the
large holes in the symmetric region to tumor segmented tissue (Fig 2-a) and
the original diﬀusion ﬁbers distorted by tumor growth were used. Despite
this, the estimated source remained stable with 1mm spatial variation along
z-axis. Its spatial disparity to the barycenter reaching a value of 3mm high-
lights that the increase of the tortuosity of the tumor quantiﬁed by the esti-
mated diﬀusivity ratio implies an increase in the distance between the tumor
barycenter and its original source (as in Patient B where it reached 5.47mm).
Since a good estimation of the spikiness index is tied to the good quality of
the acquired DT-MRI, the unexpected drop in r value from rt1 = 20 to
rt2 = 16.2 can be explained by the major tumor-inﬁltration derived anoma-
lies of the reconstructed diﬀusion tensors and also the interpolation of the
small holes therein. Both cases with various DTI anomalies demonstrated a
good performance when estimating a stable tumor source and also capturing
the spikiness of its shape through the estimated diﬀusivity ratio. However,
the prediction step was overlooked since it strongly requires a very good
quality of the symmetric DTI to the aﬀected invaded tissue.
Relying on key biological tissue characteristic (diﬀusivity in white and
grey matters), our estimation of the tumor source location and diﬀusivity
rate (or spikiness index) also showed a promising prediction of the further
spatial propagation of the glioma boundary as time evolves. The good pre-
diction in both LGG cases presented in Table 2 and Fig 7 provides additional
conﬁdence in the estimation of tumor source and diﬀusivity ratio. Note how-
ever that this spatial prediction was not based on a simulation from the
tumor origin but from the tumor boundary at a previous time point using
the estimated spikiness index. This is to avoid error accumulation leading to
a weak prediction.
DT-MRI serves as the basis for several reaction-diﬀusion based models
to extrapolate glioma invasion margins for radiation [33] and after resection
[32] using at least two acquired time points. Those two studies have been
successively evaluated on one healthy subject and one LGG patient, and they
conﬁrm that the importance of using high resolution and high quality DT-
MRI which is obviously a strong constraint. Including DT-MRI acquisitions
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in a standardized brain tumor imaging protocol would increase the number
of recruited patients and could allow a thorough validation of these models.
5. Conclusion
To go beyond the classical tumor radial expansion model which does not
take into account the tumor boundary irregularities ([31], [34], [35]), we have
introduced a new method to estimate tumor growth parameter based on a
traveling front propagation framework. The described method provides two
main patient-speciﬁc spatial characteristics of a tumor using one clinical im-
age at a single time point: its source location and an index quantifying the
irregularity of its shape. The proposed macro-scale approach was evaluated
using synthetic data and four patients with LGG. As a consequence of the
estimation of both parameters, a promising prediction of tumor spatial be-
havior was pointed out.
Some aspects of this work may be subject to improvements. For in-
stance, a sensitivity analysis of the proposed method to the choice of tumor
diﬀusion tensor in white matter is needed. Our proposed formulation leads
to eﬃcient computations, but a quantitative evaluation from experimental
datasets should help reﬁning the approach. Also, the white matter and brain
mask segmentations could be improved by using state-of-the-art image clas-
siﬁcation tools on high resolution T1 MRI for instance.
Future steps include the application of the proposed method on high-
grade gliomas and on a large database of glioma patients advancing a better
validation of the predictive power previously highlighted. This could also lead
to a statistical study of the correlation between the tumor source location, its
grade and its diﬀusivity ratio. Thus, we could check whether lower spikiness
index values are obtained for HGG since they appear to have less spiky and
irregular shapes than LGG. Including the mass eﬀect when addressing HGG
growth would be a necessary step to include in the presented methodology.
Hopefully, the coupling of mathematical models with clinical images should
lead to a better understanding of tumor growth and to useful computational
tools for diagnosis and therapy planning.
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Figure 1: Data encountered problems (Patient C): fractional anisotropy (FA) asymmetry.
(a): Non-symmetrized FA color map shows the dramatic diﬀusion signal distortion as the
region where the tumor grew seems darker than the unaﬀected brain tissue. (b): Non-
symmetrized FA color map overlayed on glioma segmentation. (d) Symmetrized FA color
map overlayed on glioma segmentation. A preliminary visual comparison between (b) and
(d) clearly shows that when symmetrizing the diﬀusion tensor image and therefore the
driven FA map, there is a tremendous loss in white matter anisotropy as most of the ﬁbers
along which the tumor originally grew disappear. The comparison of FA histograms only
computed in the segmented tumor region (c) and (d) successively corresponding to (b) and
(d) tumor ﬁgures demonstrates the anisotropy bias introduced by symmetrization process
in this case.
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Figure 2: Data encountered problems (Patient D): large black holes in the DTI. (a) Tumor
segmentation in red is overlayed on the fractional anisotropy map, a measure derived from
Diﬀusion Tensor Imaging. The signiﬁcantly missing diﬀusion signal in the contralateral
region to tumor segmented tissue prohibited our proceeding to the symmetrization process
and therefore we used for our estimation the aﬀected tissue tensors by tumor inﬁltration.
(b) The tumor boundary is drawn on the FLAIR image at the ﬁrst and second time points
in light and dark blue (in this slice they are identical) and at the third time point in red.
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Figure 3: Two axial slices of the ﬁrst included patient (Patient A) where the manually
segmented glioma (in white) is visualized on the diﬀusion tensor MR image. The sym-
metrization process in this case led to reliably recovered inﬁltration ﬁber tracts where the
simulation of tumor growth starting from a seed point is legitimate.
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Figure 4: Simulation from a source point of the iso-time contours representing the tumor
invasion process with a diﬀusivity ratio dw/dg equal to 25. The synthetic tumor displayed
in red is created by thresholding the time distance map at T = TObs. (A) represents the
axial slice, (B) coronal slice and (C) sagittal slice.
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Figure 5: The minimization surface after ﬁxing r and Sz . The x axis of this 3D plot
represents x coordinate of tumor source and the y axis represents its y coordinate.
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Figure 6: Synthetic tumors generated at diﬀerent locations with diﬀerent diﬀusivity ratios
and observation times. First row: At a ﬁxed source location, two iso-time contours with
the same observation time (TObs = 900days) are respectively colored in red for a diﬀusivity
ratio (r = 1) and in light blue (r = 50). The darker blue contour represents the tumor
further spatial invasion with (r = 50) and (Tf = 1200days). Second row: 3 synthetic
tumors are generated using the same observation time value TObs and the same diﬀusivity
ratio (r = 25) for 3 diﬀerent source locations. Third row: At the same ﬁxed location,
ﬁve iso-time contours with the same observation time are colored in red (r = 1), in blue
(r = 10), in green (r = 50) and in yellow (r = 100).
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Figure 7: Diﬀerent axial slices of Patient A showing the discrepancy between the real
boundary and the estimated one at 3 diﬀerent successive time points. First row: using
the algorithm outcome at t1, we spatially determine the tumor evolution at t2. The blue
contour represents the manually delineated tumor at the second time point and the red
one is the extracted iso-time surface SˆisoT ime. Second row: using the algorithm outcome
at t2, we predict the tumor evolution at t3. Tumor boundary at t3 is colored in blue and
the estimated one in red. Third row: using the algorithm outcome at t3, we predict the
tumor evolution at t4. Same colors are used to show the similarity between the estimated
and the ground-truth tumor contours.
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Figure 8: Evaluation curves plotted using the distance error measure CisoT ime(y%) for
y ∈ (50, 90, 100). For each patient (A or B), we try the predict the evolution at a successive
time point (A/B, ti) based on the estimated parameters at the previous one.
Figure 9: Four diﬀerent axial slices of Patient B showing the remarkable tumor boundary
spikiness evolution from the initial time point t1 to the ﬁnal one t4. Tumor contours at
successive time points are respectively colored in: dark blue for t1, light blue for t2, dark
red for t3 and light red for t4.
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Figure 10: Four diﬀerent axial slices of Patient B illustrating the prediction of the tumor
evolution based on two diﬀerent time points. Using the algorithm outcome at t2, the tumor
front is predicted at the next time point t3. The red contour represent the predicted tumor
boundary and the blue one represents the ground truth or the real tumor boundary.
Figure 11: Patient C: three diﬀerent axial slices of the manually segmented tumor bound-
ary at t1 in dark blue, at t2 in dark blue and at t3 in red.
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